Physician profile
Mayer J Hasbani
NPI 1780632968
$582,399.38
in general payments reported to CMS, 2019-2025
98 companies · $105K in 2025
The $105K reported for 2025 was more than what 98% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $49K · 2021: $84K · 2022: $108K · 2023: $81K · 2024: $85K · 2025: $105K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $156K · Food and Beverage: $40K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $30K · Consulting Fee: $28K · Travel and Lodging: $17K · Education: $912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $155,763.25 |
| Food and Beverage | $39,710.29 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $29,757.50 |
| Consulting Fee | $27,531.00 |
| Travel and Lodging | $17,382.45 |
| Education | $912.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $74,196.31 | 2023-2025 | Nuedexta, Rexulti |
| Teva Pharmaceuticals USA, INC. | $59,579.15 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $57,959.48 | 2019-2025 | |
| Eisai INC. | $56,788.46 | 2019-2025 | |
| Genzyme Corporation | $54,073.83 | 2019-2025 | |
| Acorda Therapeutics, INC | $45,108.99 | 2019-2024 | Inbrija, Ampyra |
| Amgen INC. | $40,757.09 | 2019-2025 | Uplizna, Aimovig |
| Biogen, INC. | $37,005.62 | 2019-2025 | Vumerity, Tysabri, Aduhelm |
| Lilly USA, LLC | $31,305.51 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Avanir Pharmaceuticals, INC. | $29,253.83 | 2019-2022 | |
| Allergan, INC. | $20,191.86 | 2019-2022 | |
| Kyowa Kirin, INC. | $14,008.68 | 2019-2024 | Nourianz |
| Emd Serono, INC. | $6,492.78 | 2019-2025 | Mavenclad, Mavenclad |
| Genentech USA, INC. | $6,296.52 | 2021-2025 | Ocrevus, Ocrevus Zunovo |
| Acadia Pharmaceuticals INC | $5,171.79 | 2020-2025 | Nuplazid, Daybue |
Show all 96 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $4,686.66 | 2019-2025 | Gocovri, Gocovri, Apokyn |
| Sanofi-Aventis U.S. LLC | $3,601.66 | 2023 | |
| Novartis Pharmaceuticals Corporation | $3,312.01 | 2019-2025 | |
| Sk Life Science, INC. | $2,608.78 | 2020-2025 | Xcopri |
| Amneal Pharmaceuticals LLC | $2,545.83 | 2019-2025 | Crexont, Rytary, Lyvispah |
| Lundbeck LLC | $2,098.25 | 2019-2025 | Vyepti, Rexulti |
| Medtronic USA, INC. | $2,065.12 | 2019-2020 | |
| Ucb, INC. | $1,546.93 | 2019-2025 | Rystiggo, Zilbrysq, Nayzilam |
| Supernus Pharmaceuticals, INC. | $1,300.26 | 2019-2025 | Qelbree, Qelbree |
| Argenx US, INC. | $1,282.71 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Neurocrine Biosciences, INC. | $1,248.39 | 2019-2025 | Ingrezza, Ongentys |
| Mallinckrodt Hospital Products INC. | $1,097.22 | 2020-2025 | Acthar |
| Pfizer INC. | $912.10 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $904.94 | 2020-2024 | Spravato, Invega Sustenna, Invega Trinza |
| Tg Therapeutics, INC. | $838.50 | 2023-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $752.93 | 2023-2025 | Lumryz |
| Alexion Pharmaceuticals, INC. | $745.93 | 2019-2025 | Ultomiris |
| Adamas Pharmaceuticals, INC. | $730.43 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $600.50 | 2019-2025 | Amvuttra, Onpattro |
| Csl Behring | $597.85 | 2019-2025 | Hizentra |
| Celgene Corporation | $593.91 | 2021-2025 | Zeposia |
| Horizon Therapeutics Plc | $584.42 | 2022-2023 | Uplizna |
| Neurelis, INC. | $533.75 | 2022-2025 | Valtoco |
| Grifols USA, LLC | $510.04 | 2019-2025 | Gamunex-C |
| Genentech, INC. | $497.57 | 2024-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Akcea Therapeutics, INC. | $490.69 | 2019-2021 | |
| Axsome Therapeutics, INC. | $430.66 | 2023-2025 | Symbravo, Auvelity, Sunosi |
| Upsher-Smith Laboratories LLC | $393.12 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $386.72 | 2021 | |
| Jazz Pharmaceuticals INC. | $377.39 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $350.29 | 2020-2024 | Zeposia |
| Abbott Laboratories | $309.97 | 2022-2025 | Infinity |
| Assertio Therapeutics, INC. | $299.09 | 2019 | |
| Alkermes, INC. | $284.35 | 2023-2024 | Lybalvi, Aristada, Vivitrol |
| Sunovion Pharmaceuticals INC. | $270.19 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $269.50 | 2020-2025 | Ponvory |
| Takeda Pharmaceuticals U.S.A., INC. | $249.34 | 2020-2025 | Hyqvia |
| Sumitomo Pharma America, INC. | $232.99 | 2023-2024 | Aptiom |
| Biohaven Pharmaceutical Holding Company Ltd. | $216.15 | 2022 | |
| Amylyx Pharmaceuticals, INC. | $205.61 | 2023-2024 | Relyvrio |
| Almatica Pharma LLC | $191.54 | 2021-2024 | Loreev Xr, Gralise, Teriparatide |
| Promius Pharma LLC | $177.27 | 2019 | |
| Ani Pharmaceuticals, INC. | $175.02 | 2023 | Purified Cortrophin Gel |
| Arbor Pharmaceuticals, INC. | $165.12 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $155.32 | 2023-2025 | Dysport |
| Merz Pharmaceuticals, LLC | $152.36 | 2024 | Xeomin, Inbrija |
| Janssen Biotech, INC. | $139.60 | 2025 | |
| Cycle Pharmaceuticals INC | $139.60 | 2025 | Tascenso Odt, Bafiertam |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $120.03 | 2024 | Caplyta |
| Medtronic Vascular, INC. | $114.29 | 2019 | |
| Boston Scientific Corporation | $112.24 | 2024-2025 | General - Pain Management |
| Catalyst Pharmaceuticals, INC. | $109.74 | 2021-2023 | Fycompa |
| Tempus Ai, INC | $105.03 | 2024 | |
| Avion Pharmaceuticals | $102.10 | 2021-2023 | Dhivy |
| Medtronic, INC. | $93.64 | 2023 | Percept Pc Brainsense |
| Collegium Pharmaceutical, INC. | $86.71 | 2022 | |
| Mylan Specialty L.P. | $86.47 | 2023 | |
| Impel Pharmaceuticals INC. | $82.99 | 2022 | |
| Scilex Pharmaceuticals INC. | $71.07 | 2022-2024 | Ztlido |
| Ge Healthcare | $68.71 | 2022-2025 | |
| Currax Pharmaceuticals LLC | $68.67 | 2020-2022 | |
| Mallinckrodt Enterprises LLC | $67.04 | 2019 | |
| Octapharma USA, INC. | $66.55 | 2023-2024 | Panzyga |
| Endo Pharmaceuticals INC. | $56.67 | 2019 | |
| Averitas Pharma INC. | $56.15 | 2024-2025 | Qutenza |
| Azurity Pharmaceuticals, INC. | $55.90 | 2023-2024 | Horizant, Horizant |
| Banner Life Sciences, LLC | $50.49 | 2022 | |
| Microtransponder, INC. | $50.07 | 2025 | |
| Idorsia Pharmaceuticals US INC | $42.88 | 2023-2024 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $40.28 | 2020-2023 | |
| Vertical Pharmaceuticals, LLC | $37.02 | 2019 | |
| Impel Pharmaceuticals LLC | $31.72 | 2024-2025 | Trudhesa |
| Baxter Healthcare | $28.81 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Organon LLC | $23.32 | 2022 | |
| Life Molecular Imaging Ltd | $22.43 | 2025 | Neuraceq |
| Astrazeneca Pharmaceuticals Lp | $22.21 | 2023 | |
| Grifols Shared Services North America, INC. | $18.74 | 2019 | |
| Cala Health, INC. | $15.62 | 2025 | Cala Kiq |
| Pernix Therapeutics Holdings, INC. | $15.21 | 2019 | |
| Bausch Health US, LLC | $14.66 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $13.44 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Leqembi $56KNuedexta $44KUplizna $33KRexulti $31KAustedo Xr $29KUbrelvy $15KQulipta $11KOcrevus $5,558Austedo $4,761Kesimpta $1,852Vyepti $1,323Mavenclad $1,315Gocovri $1,180Vumerity $984Acthar $853Briumvi $839Vyvgart $782Lumryz $753Tysabri $709Mayzent $691Crexont $621Lybalvi $552Nourianz $535Vyvgart Hytrulo $492Ingrezza $490Aristada $416Rytary $416Ultomiris $365Nurtec Odt $363Gamunex-C $353Zavzpret $334Panzyga $314Zeposia $309Ocrevus Zunovo $282Rystiggo $268Botox $267Valtoco $263Aptiom $233Symbravo $226Nuplazid $218Aimovig $212Ponvory $210Relyvrio $206Amyvid $199Amvuttra $196Vraylar $184Purified Cortrophin Gel $175Infinity $172Qelbree $169Dysport $155Kisunla $151Vyalev $142Xcopri $140Tascenso Odt $140Xeomin $131Spravato $128Zilbrysq $125Hyqvia $124Auvelity $122Enspryng $122Invega Trinza $122Invega Sustenna $122Bafiertam $120Caplyta $120Aduhelm $114Duopa $111Ongentys $107Tecfidera $99.05Onpattro $95.62Percept Pc Brainsense $93.64Fycompa $92.99General - Pain Management $88.04Lyvispah $84.25Nayzilam $83.12Sunosi $82.27Hizentra $79.71Vivitrol $68.49Inbrija $65.38Qutenza $56.15Xywav $55.06Loreev Xr $53.22Quviviq $42.88Horizant $33.33Emgality $32.05Trudhesa $31.72Ztlido $31.23Aubagio $29.26Hillrom - Cardiac Ambulatory Monitor $28.81Dhivy $28.42Ampyra $25.07Ongentys 50mg Capsules 30 $24.98Gralise $24.16Daybue $24.03Neuraceq $22.43Skyclarys $22.26Spinraza $22.26Betaseron $20.56Avonex $18.46Reyvow $17.60Briviact $17.39
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayer Hasbani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.